Agios Pharma (AGIO) Tops Q3 EPS by $1

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of $16.22, $1.00 better than the analyst estimate of $15.22. Revenue for the quarter came in at $9 million versus the consensus estimate of $9.47 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Anthropic, Samsung in talks for custom AI chip - The Information
• Durable Goods (May F) -4.5% vs -4.5% Expected, Ex-Trans 1.4% vs 1.3%
• Ford reports Q2 sales dip as SUVs and F-Series drive retail share